Standout Papers

Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic R... 1998 2026 2007 2016 728
  1. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma (1998)
    Sylvie Négrier, Bernard Escudier et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 17 from Science/Nature 69 standout
Sub-graph 1 of 18

Citing Papers

Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
Tertiary lymphoid structures in cancer
2022 StandoutScience
2 intermediate papers

Works of Mireille Mousseau being referenced

Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma
1998 Standout

Author Peers

Author Last Decade Papers Cites
Mireille Mousseau 641 633 620 36 1.5k
Eijiro Nakamura 565 498 463 57 1.4k
Jianqing Lin 484 838 504 61 1.7k
Xiaohong Fu 489 439 659 52 1.5k
Pasi Hirvikoski 494 1009 340 51 1.9k
Shaoyu Yan 576 891 400 38 1.8k
Jeremy Cetnar 879 362 770 42 1.4k
Satoshi Tamada 634 567 937 70 1.7k
Christos Vaklavas 565 515 273 55 1.4k
Mingxin Che 576 696 450 36 1.9k
Wolfram C. M. Dempke 711 712 384 47 1.8k

All Works

Loading papers...

Rankless by CCL
2026